This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International US West
March 9-11, 2026
San Diego Convention CenterSan Diego, CA, USA
BOOK NOW
Menu
BOOK NOW
keyboard_arrow_right

Wednesday March 11 - PT (Pacific Time, GMT-08:00)

keyboard_arrow_leftSearch & Filter
search
Wednesday March 11 - PT (Pacific Time, GMT-08:00)
search
Showing 1 of 1 Streams
8:55am - 9:00am
Chairperson's Opening Remarks: Recovery & Purification
9:00am - 9:30am
The Redox Reaction for Multispecifics
  • Dawn Ericksen-Stapleton - Principal Scientist, Pfizer
9:30am - 10:00am
Development of on-demand affinity chromatography using rabbit single-chain Fv antibodies
  • Yoichi Kumada - Professor, Kyoto Institute of Technology
10:00am - 10:30am
Cytiva
Showing 1 of 1 Streams
11:15am - 11:45am
The Role of Digitalization and Data-Driven Optimization on Downstream Processing
  • Stefano Menegatti - Professor, Chemical and Biomolecular Engineering, NC State University, North Carolina State University
11:45am - 12:15pm
Implementing Digital Twins to Support Real-Time Release in DSP
  • John Matthews - Director, Amgen
12:15pm - 12:45pm
Sponsored Talk
Showing 1 of 1 Streams
2:00pm - 2:30pm
Purification of GLP-1 Peptide Products
2:30pm - 3:00pm
Ensuring Viral Safety in AAV9 Gene Therapy Program: Potentially Platformable Approach that Delivers Robust Clearance
  • Srivatsan Ramesh - Scientist, BridgeBio Gene Therapy
Showing 1 of 1 Streams
4:15pm - 4:45pm
Product Sustainability Strategy – Addressing Environmental Impact Across the Product Lifecycle
  • Ashley Kongs - Director, Environmental Sustainability, AstraZeneca
4:45pm - 5:15pm
From Antibodies to RNA: Intensification Case Studies for the Future of Bioprocessing
  • Intensification strategies can transform biologics manufacturing, delivering both sustainability and cost-of-goods (CoGs) benefits.
  • Case studies across antibodies and and RNA demonstrate how intensification can be applied to different product types.
  • Intensification is not only about technical gains – it underpins more resilient, commercially viable, and environmentally responsible bioprocessing.
  • Philip Probert, PhD - Biologics Technology Lead, CPI Biologics
5:15pm - 5:45pm
Panel Discussion – The Future of Downstream Processing

A forward-looking discussion on how continuous processing, single-use technologies, and AI/ML-enabled purification will transform downstream operations by 2030. Leaders will examine the convergence of sustainability, automation, and supply chain resilience as drivers of the next generation of biomanufacturing.

  • Philip Probert, PhD - Biologics Technology Lead, CPI Biologics
Tuesday March 10
Filter
Streams
Clear
Formats
Choose Day